Industry Insights
-
Treating Deficiencies In Employee Training And Mentorship
5/3/2024
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
Unleashing The Power Of Investigator-Sponsored Research (ISR) And Investigator-Initiated Trials (IIT)
5/3/2024
Investigator-sponsored research (ISR) and investigator-initiated trials (IIT) are essential to expanding the drugs currently available or under investigation, either alone or in combination, to address unmet medical needs.
-
A Strategic Framework For Positive Site-Sponsor Relationships
5/1/2024
Through an examination of evolving trial strategies and implementation, we aim to lay the groundwork for a collaborative, mutually beneficial atmosphere, ultimately leading to a sustainable competitive edge.
-
Using Tech Enabled Solutions To Boost Productivity And Sustainability
5/1/2024
Clinical trials continue to face challenges related to cost, patient technology adoption, and resource management. Uncover how investing in suitable tech solutions can enhance efficiency and reduce companies' carbon footprint.
-
Experts Discuss AI’s Future In Pharma
5/1/2024
At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.
-
How Partnership Ensured A Successful First Digital Trial
5/1/2024
Discover how this collaborative approach and tailored recommendations led to the successful implementation of an eConsent tool for a kidney cancer study with U.S. Renal Care.
-
No Delays: How To Achieves A 99% Device Shipment Rate
5/1/2024
Boasting a 99% device shipment rate, uncover how the success stems from expert teams employing a proven model, including partnership building, customized expertise development, and proactive supply chain and technology management.
-
Shifting The Approach: 4 Strategies For ICH E6(R3) Implementation
4/30/2024
In addition to codifying some best practices, R3 suggests sponsors take a proportionate approach to identifying and managing areas of risk.
-
Early Exposure & Site Network Support Enable PI’s Enduring Interest In Research
4/30/2024
Seasoned Phase 1 principal investigator and site co-director Manish Sharma, MD, recounts his career thus far as a PI, offering insights into PI motivation, retention, and satisfaction.
-
Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression
4/30/2024
MindBio Therapeutics CEO Justin Hanka details the company’s Phase 2a clinical trial investigating the use of a take-home microdosing regimen for depression.